ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,249Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 143

$1.62M Total Retail Price of All Prescriptions

Rank: 1 out of 143

642 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 642 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

15% of this provider’s 642 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 15,076 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$89 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
OMEPRAZOLE 529 396 1 5
LEVOTHYROXINE SODIUM 478 404 2 3
FUROSEMIDE 454 400 3 6
TRAMADOL HCL 433 330 4 16
SIMVASTATIN 382 317 5 2
METOPROLOL TARTRATE 330 321 6 12
WARFARIN SODIUM 329 324 7 15
CARVEDILOL 322 236 8 22
ATORVASTATIN CALCIUM 318 298 9 7
LISINOPRIL 309 224 10 1
AMLODIPINE BESYLATE 296 270 11 4
PRAVASTATIN SODIUM 280 231 12 9
MIRTAZAPINE 270 242 13 30
METFORMIN HCL 267 194 14 8
POLYETHYLENE GLYCOL 3350 240 190 15 45
CRESTOR 234 130 16 17
HYDROCODONE-ACETAMINOPHEN 232 183 S3 17 20
LOSARTAN POTASSIUM 227 217 18 19
METOPROLOL SUCCINATE 212 186 19 14
ZOLPIDEM TARTRATE 208 151 20 13
CITALOPRAM HBR 203 189 21 25
PANTOPRAZOLE SODIUM 194 171 22 43
ESCITALOPRAM OXALATE 191 167 23 46
BYSTOLIC 188 151 24 87
DIOVAN 173 118 25 26
QUETIAPINE FUMARATE 171 167 26 53
RANITIDINE HCL 166 149 27 41
NOVOLOG FLEXPEN 156 149 28 85
SERTRALINE HCL 149 126 29 23
GABAPENTIN 147 117 30 18
SPIRIVA 139 113 31 38
CLOPIDOGREL 138 128 32 33
TAMSULOSIN HCL 137 125 33 28
CYMBALTA 133 103 34 47
NAMENDA 131 126 35 49
GLIMEPIRIDE 131 94 35 27
DONEPEZIL HCL 128 128 37 36
FLUTICASONE PROPIONATE 126 86 38 37
LEVEMIR FLEXPEN 125 96 39 162
FENTANYL 123 110 S2 40 83
OLANZAPINE 118 112 41 100
CIPROFLOXACIN HCL 118 110 41 58
PREDNISONE 117 105 43 35
ISOSORBIDE MONONITRATE ER 115 113 44 44
DIGOXIN 112 104 45 71
NEXIUM 111 64 46 32
MELOXICAM 110 99 47 78
CEPHALEXIN 107 105 48 119
LEVETIRACETAM 106 85 49 74
POTASSIUM CHLORIDE 103 99 50 34
PLAVIX 99 92 51 51
CYCLOBENZAPRINE HCL 89 36 R 52 77
OXYCODONE HCL 88 67 S2 53 29
EXELON 83 83 54 185
IPRATROPIUM-ALBUTEROL 82 82 55 103
LIPITOR 78 70 56 57
SEROQUEL 74 74 57 146
CLOTRIMAZOLE-BETAMETHASONE 74 61 57 159
ACTONEL 72 63 59 161
FLUOXETINE HCL 72 62 59 101
ATENOLOL 72 71 59 11
PROMETHAZINE HCL 72 48 R 59 139
DIOVAN HCT 71 51 63 60
ALENDRONATE SODIUM 71 57 63 40
NOVOLOG MIX 70-30 FLEXPEN 71 67 63 133
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 58 66 21
EXFORGE 69 63 67 132
RISPERIDONE 69 58 67 61
AGGRENOX 68 49 69 194
NOVOFINE AUTOCOVER 67 67 70 195
BUPROPION XL 67 45 70 88
FINASTERIDE 67 63 70 97
BACLOFEN 67 39 70 123
ZETIA 66 51 74 75
LEXAPRO 65 54 75 141
PROAIR HFA 65 33 75 48
PRAMIPEXOLE DIHYDROCHLORIDE 65 49 75 199
AMOX TR-POTASSIUM CLAVULANATE 64 57 78 112
DIVALPROEX SODIUM 63 48 79 80
ADVAIR DISKUS 63 58 79 42
LACTULOSE 61 51 81 116
ERYTHROMYCIN 59 59 82 169
HYDRALAZINE HCL 59 56 82 64
KLOR-CON M20 58 46 84 69
NAPROXEN 56 22 85 81
CHLORHEXIDINE GLUCONATE 54 48 86 164
RAMIPRIL 54 54 86 106
CLOBETASOL PROPIONATE 53 40 88 215
SPIRONOLACTONE 51 37 89 122
OXYCONTIN 51 37 S2 89 111
SYNTHROID 51 49 89 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.